Global transcatheter aortic valve replacement (TAVR) market is expected to reach

Posted by rohan on December 6th, 2017

Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high risk patients. Transcatheter heart valve replacement systems are referred as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).

Growing adoption of minimally invasive therapies, increasing number of severe aortic stenosis disorder patients, rising number of clinical trials cardiovascular indications, and growing number of product launches in this market are driving the growth of global transcatheter aortic valve replacement (TAVR) market. In addition, rising technological advancements, increasing demand for minimally invasive catheter-based procedures as compared to conventional open heart therapies, and growing number of patients choosing an efficient & effective therapy with quick recovery are further propelling the growth of global transcatheter aortic valve replacement (TAVR) market. However, risk associated with TAVR procedures, high costs pertaining to transcatheter aortic valves, lack of skilled professionals in certain regions of developing markets, and device related issues (such as device recalls, improper positioning of devices during implantation) are some of the factors restraining the growth of global transcatheter aortic valve replacement (TAVR) market.

View full report @ http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/

Global transcatheter aortic valve replacement (TAVR) market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users. Based on surgery method, the market is sub-segmented as transfemoral implantation, transapical implantation, transaortic implantation, and transcaval implantation. Of these, transfemoral is estimated to command the largest share of global transcatheter aortic valve replacement (TAVR) market by surgery method in 2016 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, the market is segmented as nitinol, stainless steel, and cobalt-chromium. Of these, nitinol segment is expected to account for the largest share of global transcatheter aortic valve replacement (TAVR) market by valve frame material in 2016.

Transcatheter valve size market is segmented as 14mm to 18mm, 18mm to 22mm, and 22mm to 29mm. Based on valve leaflets material, the market is segmented as bovine heart tissue, cow heart tissue, and other valve leaflets material. Based on end users, the market is sub-segmented as hospitals, ambulatory surgical centres, & cardiac catheterization laboratories. Of these, hospital segment held the largest share of global transcatheter aortic valve replacement (TAVR) market by end users in 2016.

Market Segmentation:                                                              

                1 Introduction                                               

                2 Surgery Method                                       

                                2.1 Introduction                           

                                2.2 Transfemoral Implantation                              

                                2.3 Transapical Implantation                   

                                2.4 Transaortic Implantation                   

                                2.5 Transcaval Implantation                    

                3 Valve Frame Material                                             

                                3.1 Introduction                           

                                3.2 Nitinol                       

                                3.3 Stainless Steel                       

                                3.4 Cobalt-Chromium                

                4 Valve Size                                    

                                4.1 Introduction                           

                                4.2 14mm to 18 mm                    

                                4.3 18mm to 22 mm                    

                                4.4 22mm to 29mm                     

                5 Valve Leaflets Material                                          

                                1 Introduction                           

                                2 Bovine Heart Tissue                            

                                3 Cow Heart Tissue                 

                                4 Other Valve Leaflets Material                         

                6 End Users                                    

                                6.1 Introduction                           

                                6.2 Hospitals                  

                                6.3 Ambulatory Surgical Centres                           

                                6.4 Cardiac Catheterization Laboratories         

                                                                                                                     

Get free sample report @ http://www.marketdataforecast.com/market-reports/transcatheter-aortic-valve-replacement-market-357/request-sample

On the basis of geographical region the global transcatheter aortic valve replacement (TAVR) market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is estimated to command the highest share of 34% of the global transcatheter aortic valve replacement (TAVR) market in 2016, whereas Asia-Pacific is estimated to grow at the highest CAGR of 21.20% during the forecast period 2016-2021.

Scope of the report:

  • Global, regional and country-level analysisand forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysisin terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC)in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysisfor analysing the level of competition and business strategy development
  • A comprehensive list of key market playersalong with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysislisting out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunitiesto provide both individuals and organizations a strong financial foothold in the market

Buy now@ http://www.marketdataforecast.com/cart/buy-now/transcatheter-aortic-valve-replacement-market-357

The key players in global transcatheter aortic valve replacement (TAVR) market such as, Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).

About Market Data Forecast:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

 

Like it? Share it!


rohan

About the Author

rohan
Joined: September 20th, 2017
Articles Posted: 1,346

More by this author